Clinical Site 109 — Liverpool, New York

Clinical Site 109 is a clinical research site located in Liverpool, New York, United States 13088.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Clinical Site 109 has participated in 1 clinical trials.

Therapeutic areas: Diabetic Retinopathy.

Sponsors: OcuTerra Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Site 109?

Clinical Site 109 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Site 109 conducted?

Clinical Site 109 has 1 clinical trials on record. Their work covers Diabetic Retinopathy.

Is Clinical Site 109 accredited by Crixeo Health?

Clinical Site 109 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Site 109?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.